Prosecution Insights
Last updated: July 05, 2026

Examiner: HARVEY-BUTLER, AVANDA ELEXA

Tech Center 1600 • Art Units: 1634 1683

This examiner grants 0% of resolved cases

Performance Statistics

Allow Rate
-60.0% vs TC avg
14
Total Applications
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

32.1%
§101 Eligibility
0%
§102 Novelty
64.3%
§103 Obviousness
0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17872597 ANALYSIS OF CELL-FREE DNA IN URINE AND OTHER SAMPLES Final Rejection The Chinese University of Hong Kong
18683969 PHARMACOGENOMICS SCORE TO MAKE DECISIONS ON THERAPY AUGMENTATION IN AML Non-Final OA University of Tennessee Research Foundation
18527992 REAGENT EXCHANGE IN AN INSTRUMENT Non-Final OA ILLUMINA, INC.
17892804 CIRCULATING MICRORNA AS A MARKER FOR HEPATOCELLULAR CARCINOMA Non-Final OA Quest Diagnostics Investments LLC
18600305 KIT FOR CALIBRATION OF ISOTHERMAL POLYMERASE CHAIN REACTION (PCR) ANALYZER AND USE THEREOF Non-Final OA National Institute of Metrology, China
18370117 RAPID MOLECULAR DIAGNOSTICS WITH UNIFIED-ONE-POT SAMPLE PROCESSING, NUCLEIC ACID AMPLIFICATION, AND RESULT READOUT Non-Final OA DOMUS DIAGNOSTICS, INC.
18322595 DETECTION METHOD OF AMMONIA OXIDATION FUNCTIONAL GENE IN WATER TREATMENT Non-Final OA Chung Yuan Christian University
17761866 METHOD AND SYSTEM FOR TARGETED NUCLEIC ACID SEQUENCING Final Rejection JUMPCODE GENOMICS, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month